CAS 310457-07-9

N-(4-Bromobenzoyl)-β-alanine

Description:

N-(4-Bromobenzoyl)-β-alanine is an organic compound characterized by its structure, which includes a β-alanine moiety linked to a 4-bromobenzoyl group. This compound features a bromine atom substituted on the benzene ring, which can influence its reactivity and biological activity. The presence of the carboxylic acid and amine functional groups in β-alanine contributes to its properties as an amino acid derivative. Typically, such compounds exhibit moderate solubility in polar solvents due to their polar functional groups, while the bromine substitution can enhance lipophilicity. N-(4-Bromobenzoyl)-β-alanine may be of interest in pharmaceutical research, particularly in the development of bioactive molecules or as a potential intermediate in organic synthesis. Its unique structural features may also impart specific interactions in biological systems, making it a candidate for studies in medicinal chemistry. As with many organic compounds, safety and handling precautions should be observed due to potential toxicity associated with brominated compounds.

Formula: C₁₀H₁₀BrNO₃

InChI: InChI=1S/C10H10BrNO3/c11-8-3-1-7(2-4-8)10(15)12-6-5-9(13)14/h1-4H,5-6H2,(H,12,15)(H,13,14)

InChI key: InChIKey=AWXOXDFIMZLYSX-UHFFFAOYSA-N

SMILES: C(NCCC(O)=O)(=O)C1=CC=C(Br)C=C1

Synonyms:

• N-(4-Bromobenzoyl)-β-alanine
• 3-[(4-Bromophenyl)formamido]propanoic acid
• β-Alanine, N-(4-bromobenzoyl)-

3-[(4-Bromophenyl)formamido]propanoic acid

CAS: 310457-07-9

3-[(4-Bromophenyl)formamido]propanoic acid is a potent inhibitor of protein interactions and an activator of Ligand, Receptor, and Ion channels. 3-[(4-Bromophenyl)formamido]propanoic acid binds to specific receptors on the cell surface, which triggers the opening of ion channels, causing hyperpolarization in neurons. This inhibition prevents neurotransmitter release from the presynaptic terminal, thereby blocking neural transmission. 3-[(4-Bromophenyl)formamido]propanoic acid is used as a research tool to study protein interactions and receptor activation. It has also been shown to be an effective treatment for epilepsy in rats.

Formula: C₁₀H₁₀BrNO₃

Purity: Min. 95%

Molecular weight: 272.09 g/mol

Ref: 3D-KMA45707